James Island pharmacist weighs in on newly approved medication
The Rise of Non-Opioid Painkillers: A Revolutionary Shift The recent approval of Journavx, or suzetrigine, by the U.S. Food and Drug Administration (FDA) marks the advent of a groundbreaking class of non-opioid painkillers poised to transform pain management. Developed by Vortex Pharmaceuticals, this drug is intended to treat moderate to severe acute pain stemming from … Read more